PerkinElmer, Inc. (PKI) Financial Analysis & Valuation | Quarter Chart
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions... more
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and ... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $14.46B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Diagnostics & Research |
| Country | US | CEO | Prahlad R. Singh |
| IPO Date | 1983-04-06 | CAGR | 2.29% |
| Employees | 16,700 | Website | www.perkinelmer.com |
| Div. Yield | 0.24% | Payout Ratio | 13% |
| Buy Back Yield | 0.82% | Total Yield | 1.06% |
PKI chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $15.76B | P/E | 41.45 | Forward P/E | — | PEG | — |
| P/S | 4.41 | P/B | 1.78 | P/CF | 20.32 | P/FCF | 22.79 |
| Sales | $2.91B | Sales 1Y | 7.89% | Sales 3Y | -36.22% | Sales 5Y | -9.95% |
| EPS | $2.78 | EPS 1Y | 740% | EPS 3Y | -57.14% | EPS 5Y | -42.93% |
| Sales QoQ | 2.61% | EPS QoQ | 30.56% | Sales QoQ Avg | 0.55% | EPS QoQ Avg | 19.1% |
| Gross Margin | 52.11% | Operating Margin | 12.32% | Profit Margin | 8.16% | ROCE | 3.33% |
| ROA | 2% | ROE | 3% | Altman Z Score | 2.22 | Piotroski Score | 7 |
| Current Ratio | 1.8 | Quick Ratio | 1.5 | Cash Ratio | 0.8 | Op. CF Ratio | 0.05 |
| Debt/Equity | 0.46 | Debt/Assets | 0.28 | Lt Debt/Equity | 0.38 | Lt Debt/Cap. | 0.27 |
| Intrst Cov. | 3.82 | Inventory Turnover | 3.68 | Asset Turnover | 0.24 | Receivables Turnover | 4.11 |
| Enterprise Value | $15.76B | P/E Ratio | 41.45 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 4.41 | P/B Ratio | 1.78 |
| P/CF Ratio | 20.32 | P/FCF Ratio | 22.79 |
| EPS | $2.78 | EPS Growth 1Y | 740% |
| EPS Growth 3Y | -57.14% | EPS Growth 5Y | -42.93% |
| Revenue Growth 1Y | 7.89% | Gross Margin | 52.11% |
| Operating Margin | 12.32% | Profit Margin | 8.16% |
| ROE | 3% | ROA | 2% |
| ROCE | 3.33% | Current Ratio | 1.8 |
| Quick Ratio | 1.5 | Cash Ratio | 0.8 |
| Debt/Equity | 0.46 | Interest Coverage | 3.82 |
| Altman Z Score | 2.22 | Piotroski Score | 7 |
PerkinElmer, Inc. (PKI) valuation & financials
PerkinElmer, Inc. (PKI) has a market capitalization of $14.46B and trades at a price-to-earnings ratio of 41.5. It operates in the Healthcare sector (Medical - Diagnostics & Research).
PerkinElmer, Inc.'s revenue grew +7.9% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)